For scintigraphic imaging of cancers, including PET scans, and management of thyroid pathologies, including cancers.
Outpatient consultations
Secretariat
- Opening hours: Appointments are available Monday to Friday, 8:30 a.m. to 5 p.m.
- Telephone: 02 31 45 50 32
- Location: Centre ground floor
Hospitalization
Sheltered hospitalization
- Open: 24-hour service
- No visit
- Hospital secretariat: Monday to Friday, 8.30am to 4.30pm: 02 31 45 50 50 ext. 53.73
- Nursing office: 02 31 45 50 50 ext. 53.73
- Location: 7th floor
Department tasks
Care mission
The Nuclear Medicine Department is involved in the diagnosis and treatment of thyroid cancer (iodine-131 and systemic therapies), prostate cancer (Pluvicto), and neuroendocrine tumors (Lutathera). It treats patients with thyroid cancer and refractory thyroid cancer.
Its main mission is to carry out :
- scintigraphic imaging (PET including various tracers and scintigraphs),
- metabolic radiotherapy treatments (iodine-131, targeted internal radiotherapy (TIRT) with Lutathera, PSMA-targeted internal radiotherapy (PSMA-TIRT) with Pluvicto),
- thyroid pathology consultations (thyroid nodules, thyroid cancer, hyperthyroidism, hypothyroidism...),
- thyroid ultrasound (with cytopunctions).
Research mission
The department is involved in research on nuclear medicine and thyroid disorders.
Teaching mission
Each year, the department’s physicians participate in various initial and continuing education programs for medical residents and interns, pharmacy residents and interns, and medical radiology technician trainees. The department also serves as a clinical training site for residents, interns, and medical radiology technician trainees.
The team
- Department Head: Dr Stéphane BARDET
- Health executive: Antoine MARIE
- Nuclear medicine physicians: Dr. Stéphane BARDET, Dr. Renaud CIAPPUCCINI, Dr. Elisabeth QUAK
- Thyroid Consultations: Dr. Stéphane BARDET, Dr. Paul-Antoine BOMPAIN, Dr. Renaud CIAPPUCCINI, Dr. Véronique LE HENAFF, Dr. Barbara LIREUX
- Radiation protection: Alain BATALLA
- Medical physicist: Cyril JAUDET
- Radiopharmacists: Dr Gauthier FOUCRAS, Dr Anaïs PRIGENT
Care services
For diagnostic purposes
Nuclear medicine enables us to explore the functioning of numerous organs and detect diseased tissue, in a targeted population ranging from infants to the elderly. Scintigraphy procedures vary from one type of examination to another, and are adapted to the clinical situation of each patient. In general, examinations are carried out in two stages: the first involves injection of the radioactive drug, followed a few minutes to a few hours later by the 2nd stage, when the images are taken.
The Centre's nuclear medicine department is particularly dedicated to oncology and endocrine investigations, including :
- FDG PET
- Gallium-68 PSMA PET Scan
- Gallium-68 DOTA-Toc PET scan
- Bone scintigraphy with SPECT/CT
- Thyroid scintigraphy
- Fluorocholine PET for parathyroid imaging
- Isotopic calculation of the left ventricular ejection fraction (LVEF)
- Sentinel lymph node mapping for breast, skin, head and neck, and gynecological cancers
The department has set up a Thyroid Rapid Diagnosis Day.
Therapeutic use
Nuclear medicine is involved in the management of a number of diseases. The department is involved in the treatment of :
- Benign and malignant thyroid diseases (I131)
- Prostate cancer (PLUVICTO)
- Neuroendocrine tumors of the small intestine (LUTATHERA)
- Neuroblastoma (MIBG-I131)
Expertise
- Expertise in scintigraphic imaging including PET
- Expertise in thyroid pathologies, including cancers(TUTHYREF network expert center). Local and regional thyroid RCP.
- Expertise in metabolic radiotherapy, thanks to the availability of radiation-shielded rooms (Iodine-131, PLUVICTO, and LUTATHERA)
Equipment
- 3 gamma cameras :
- 1 BRIVO GE (2016)
- 1 INTEVO bold Siemens (2020) coupled to an X-ray location scanner
- 1 Pro-SPECTA Siemens (2025) paired with a positioning X-ray scanner
- 1 Philips Vereos CT scanner (2017)
- 5 radiation-shielded rooms
Results
- Accreditations: EARL FDG PET/CT Center of Excellence – EARL Level 2 Theranostics
- Expert center for the national TUTHYREF network (THYroid REFractory Tumors)
- More than 5,000 scintigraphy procedures
- Over 5,700 TEP of Vereos
- More than 2,300 thyroid consultations
- 241 rapid thyroid consultations
- 434 metabolic radiotherapy treatments
Research / Project
- Thyroid nodules
- PET : Instrumentation
- Parathyroid and FCH PET
Partnerships
- At the national level: TUTHYREF , working groups of the French Society of Nuclear Medicine (SFMN)
Publications
- Leboulleux S et al. Thyroidectomy without radioiodine in patients with low-risk thyroid cancer: 5 years of follow-up from the prospective randomized ESTIMABL2 trial. Lancet Diabetes Endocrinol. Jan 2025;13(1):38-46. doi: 10.1016/S2213-8587(24)00276-6. Published online Nov 22, 2024.
- Elske Quak et al. F18-Choline PET/CT vs. MIBI SPECT/CT in the Surgical Management of Primary Hyperparathyroidism: A Diagnostic Randomized Clinical Trial. JAMA Otolaryngol Head Neck Surg. 2024 Aug 1;150(8):658-665. doi: 10.1001/jamaoto.2024.1421.
- Renaud Ciappuccini et al. 18F-Fluorocholine Positron Emission Tomography/Computed Tomography Is a Highly Sensitive but Poorly Specific Tool for Identifying Malignancy in Thyroid Nodules with Indeterminate Cytology: The Chocolate Study. Thyroid 2020
Training courses
Initial training
- Training medical electroradiology technicians
- Training medical interns and externs as part of their hospital internships